Related references
Note: Only part of the references are listed.Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria
Thomas A. Forbes et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase
Mirco Dindo et al.
PROTEIN SCIENCE (2022)
Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases
Elizabeth C. Lorenz et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Lumasiran: First Approval
Lesley J. Scott et al.
DRUGS (2021)
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
Sander F. Garrelfs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach
Gioena Pampalone et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2021)
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations
Ludovica Liguori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
Tae-Un Han et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Sterically Hindered Amination of Aryl Chlorides Catalyzed by a New Carbazolyl-Derived P,N-Ligand-Composed Palladium Complex
Wing In Lai et al.
SYNTHESIS-STUTTGART (2019)
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1
Mirco Dindo et al.
BIOCHEMICAL JOURNAL (2019)
Systematic Computational Design and Identification of Low Picomolar Inhibitors of Aurora Kinase A
Hwangseo Park et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
Radiation damage at the active site of human alanine: glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis
Giorgio Giardina et al.
SCIENTIFIC REPORTS (2017)
Pharmacological Chaperones: Design and Development of New Therapeutic Strategies for the Treatment of Conformational Diseases
Marino Convertino et al.
ACS CHEMICAL BIOLOGY (2016)
Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay
Sonia Fargue et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I
Elisa Oppici et al.
ACS CHEMICAL BIOLOGY (2015)
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine
Riccardo Montioli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview
Elisa Oppici et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Review of combined liver and kidney transplantation in children
Rainer Ganschow et al.
PEDIATRIC TRANSPLANTATION (2015)
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes
Barbara Cellini et al.
CLINICAL BIOCHEMISTRY (2014)
Vitamin B6 in Primary Hyperoxaluria I: First Prospective Trial after 40 Years of Practice
Heike Hoyer-Kuhn et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Using pharmacological chaperones to restore proteostasis
Ya-Juan Wang et al.
PHARMACOLOGICAL RESEARCH (2014)
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase
Elisa Oppici et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
TAT-Mediated Delivery of Human Alanine:Glyoxylate Aminotransferase in a Cellular Model of Primary Hyperoxaluria Type I
Alessandro Roncador et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2013)
Four of the Most Common Mutations in Primary Hyperoxaluria Type 1 Unmask the Cryptic Mitochondrial Targeting Sequence of Alanine:glyoxylate Aminotransferase Encoded by the Polymorphic Minor Allele
Sonia Fargue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Primary Hyperoxaluria
Pierre Cochat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Protein Homeostasis Defects of Alanine-Glyoxylate Aminotransferase: New Therapeutic Strategies in Primary Hyperoxaluria Type I
Angel L. Pey et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Primary hyperoxalurias: Disorders of glyoxylate detoxification
Eduardo Salido et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment
Pierre Cochat et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Progress Curve Mechanistic Modeling Approach for Assessing Time-Dependent Inhibition of CYP3A4
Howard J. Burt et al.
DRUG METABOLISM AND DISPOSITION (2012)
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants
Barbara Cellini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant
Barbara Cellini et al.
BIOCHIMIE (2010)
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I
Barbara Cellini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Construction, Purification and Characterization of Untagged Human Liver Alanine-Glyoxylate Aminotransferase Expressed in Escherichia coli
Carla Voltattorni et al.
PROTEIN AND PEPTIDE LETTERS (2010)
Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine: Glyoxylate Aminotransferase and the F152I Mutation
Barbara Cellini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
In Vivo and in Vitro Examination of Stability of Primary Hyperoxaluria-associated Human Alanine: Glyoxylate Aminotransferase
Erin D. Hopper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Synthesis of N-alkoxyphthalimides under ultrasound irradiation
Shu-Xiang Wang et al.
ULTRASONICS SONOCHEMISTRY (2008)
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant:: functional properties and physiological implications
Barbara Cellini et al.
BIOCHEMICAL JOURNAL (2007)
Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways
Christopher J. Danpure
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells
JI Behnam et al.
BIOCHEMICAL JOURNAL (2006)
Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele
CG Monico et al.
KIDNEY INTERNATIONAL (2005)
Implications of genotype and enzyme phenotype in pyridoxine response of patients with type I primary hyperoxaluria
CG Monico et al.
AMERICAN JOURNAL OF NEPHROLOGY (2005)
Molecular aetiology of primary hyperoxaluria type 1
CJ Danpure
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Primary hyperoxaluria type 1 in the Canary Islands:: A conformational disease due to I244T mutation in the P11 L-containing alanine:glyoxylate aminotransferase
A Santana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
